$265 Million is the total value of TRV GP IV, LLC's 3 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TANGO THERAPEUTICS, INC. | $218,038,359 | +239.2% | 19,363,975 | 0.0% | 82.15% | +41.4% | ||
| PLRX | PLIANT THERAPEUTICS, INC. | $36,983,914 | -4.3% | 2,132,867 | 0.0% | 13.93% | -60.1% | |
| FULC | FULCRUM THERAPEUTICS, INC. | $10,403,604 | +34.5% | 2,343,154 | 0.0% | 3.92% | -43.9% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MAGENTA THERAPEUTICS, INC. | 17 | Q4 2022 | 100.0% |
| FULCRUM THERAPEUTICS, INC. | 17 | Q3 2023 | 25.6% |
| PLIANT THERAPEUTICS, INC. | 14 | Q3 2023 | 40.6% |
| REVOLUTION MEDICINES, INC. | 12 | Q4 2022 | 28.4% |
| TANGO THERAPEUTICS, INC. | 9 | Q3 2023 | 82.1% |
| RELAY THERAPEUTICS, INC. | 2 | Q4 2020 | 41.2% |
View TRV GP IV, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-02-21 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-10 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-14 |
| 4 | 2023-02-09 |
| 13F-HR | 2022-11-03 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-10 |
View TRV GP IV, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.